Otros idiomas Biogened S.A.

Acciones

BGD

PLBIOGN00018

Precio de cierre Warsaw S.E. Otros sitios de cotización 00:00:00 16/05/2024			Varia. Cinco días.	Varia. 1 de enero.
22,4 ^PLN	-2,61 %		+1,82 %	+24,44 %

14/02	Biogened S.A. informa de los resultados del cuarto trimestre y del año completo finalizado el 31 de diciembre de 2023	CI
2023	Biogened S.A. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 30 de septiembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Biogened S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02
Biogened S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Biogened S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Biogened S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	14/02/23
Biogened S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	14/02/23
Biogened S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Biogened S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22
Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
Biogened S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	14/02/22
Biogened S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	14/02/22
Biogened S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21
Biogened S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/08/21
Biogened S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	12/02/21
Biogened S A : Raport kwartalny za II kwartał 2020 roku	14/08/20
Biogened S.A. Announces Dividend, Payable on November 11, 2020	29/07/20
Biogened S.A. Receives FDA Approval for Vumerity for Multiple Sclerosis	11/11/19
Biogened S.A. announced that it expects to receive PLN 0.5 million in funding	19/05/17
Biogened S.A. announced that it has received PLN 3 million in funding	29/11/16

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Biogened S.A.

Acciones

BGD

PLBIOGN00018

Otros idiomas

Filtros